Literature DB >> 7715774

Fluctuations in nucleus accumbens dopamine during cocaine self-administration behavior: an in vivo electrochemical study.

E A Kiyatkin1, E A Stein.   

Abstract

High-speed chronoamperometry with Nafion-coated monoamine-sensitive carbon fiber electrodes was used to estimate changes in extracellular dopamine concentration in the nucleus accumbens during cocaine self-administration behavior in rats. In trained animals, time-locked biphasic fluctuations in dopamine-dependent electrochemical signal were found to accompany cocaine self-injections (0.8-0.9 mg/kg/inj). The mean signal gradually increased by the equivalent of 20-30 nM of dopamine during the 60 s preceding the injection, reached a peak value at the lever-press and decreased abruptly by about 20-30 nM for 40-60 s after the injection. This cyclic pattern was repeated with the next lever-press. The post-cocaine signal decreases were most pronounced during the first 30 min of each session, when self-administration behavior was highest (eight to 16 injections), and gradually diminished during the session. In contrast, the pre-injection signal increases became enhanced over time. Lever-presses reinforced by a double cocaine dose were followed by significantly larger and longer lasting signal decreases. These biphasic fluctuations quickly disappeared after several non-reinforced lever-presses. Although experimenter-delivered cocaine injections paced to mimic the pattern of self-administration also induced biphasic signal fluctuations, both the post-drug signal decreases and subsequent pre-injection increases were significantly smaller. It is hypothesized that the increases in signal seen in trained animals are a consequence of cocaine-induced dopamine uptake inhibition following behavior-associated dopamine cell activation. In contrast, the post-cocaine abrupt transient signal depression may be related to a decrease in mesolimbic dopamine release due to inhibition of dopamine cell activity. Signal decreases seen after self-administered procaine suggest that cocaine's local anesthetic action may contribute to this decrease in dopamine release. Additionally, while the latency of response differed somewhat, since apomorphine administration also led to a reduction in signal, autoreceptor activation may also have contributed to the cocaine-induced signal depression. That learning and behavioral mechanisms are also important determinants of the observed cocaine-induced signal changes is suggested by the signal decreases after the first non-reinforced responses, signal differences between self- and passively-administered cocaine and signal increases caused by cocaine-related cues. In light of numerous neuropharmacological studies implicating the significance of the mesolimbic dopamine system in the organization and regulation of goal-directed behaviors, these data suggest that mesolimbic dopamine system activation may mediate motivational and activational components of drug-seeking and drug-taking behavior, while the transient, reward-associated inhibition of the system may be involved in regulating these behaviors.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7715774     DOI: 10.1016/0306-4522(94)00436-9

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  24 in total

1.  Firing rate of nucleus accumbens neurons is dopamine-dependent and reflects the timing of cocaine-seeking behavior in rats on a progressive ratio schedule of reinforcement.

Authors:  S M Nicola; S A Deadwyler
Journal:  J Neurosci       Date:  2000-07-15       Impact factor: 6.167

2.  The role of peripheral and central sodium channels in mediating brain temperature fluctuations induced by intravenous cocaine.

Authors:  Eugene A Kiyatkin; P Leon Brown
Journal:  Brain Res       Date:  2006-09-07       Impact factor: 3.252

3.  Real-time measurement of dopamine fluctuations after cocaine in the brain of behaving rats.

Authors:  Michael L A V Heien; Amina S Khan; Jennifer L Ariansen; Joseph F Cheer; Paul E M Phillips; Kate M Wassum; R Mark Wightman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

4.  Dopamine and glutamate release in the dorsolateral caudate putamen following withdrawal from cocaine self-administration in rats.

Authors:  Amanda Gabriele; Alejandra M Pacchioni; Ronald E See
Journal:  Pharmacol Biochem Behav       Date:  2012-09-28       Impact factor: 3.533

Review 5.  Brain temperature and its role in physiology and pathophysiology: Lessons from 20 years of thermorecording.

Authors:  Eugene A Kiyatkin
Journal:  Temperature (Austin)       Date:  2019-12-03

6.  Hold-down as an alternative to unit dose in cocaine self-administration experiments: Characterization using a progressive ratio schedule.

Authors:  David C S Roberts; Benjamin A Zimmer
Journal:  Psychopharmacology (Berl)       Date:  2020-05-28       Impact factor: 4.530

7.  Effects of allopregnanolone on the reinstatement of cocaine-seeking behavior in male and female rats.

Authors:  Justin J Anker; Nathan A Holtz; Natalie Zlebnik; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2008-11-08       Impact factor: 4.530

8.  Patterns of functional activity associated with cocaine self-administration in the rat change over time.

Authors:  Darrel J Macey; Wendy N Rice; Cory S Freedland; Christopher T Whitlow; Linda J Porrino
Journal:  Psychopharmacology (Berl)       Date:  2003-12-11       Impact factor: 4.530

9.  Cocaine-induced mu opioid receptor occupancy within the striatum is mediated by dopamine D2 receptors.

Authors:  Avery R Soderman; Ellen M Unterwald
Journal:  Brain Res       Date:  2009-08-20       Impact factor: 3.252

10.  Electrophysiological evidence of mediolateral functional dichotomy in the rat accumbens during cocaine self-administration: tonic firing patterns.

Authors:  Anthony T Fabbricatore; Udi E Ghitza; Volodymyr F Prokopenko; Mark O West
Journal:  Eur J Neurosci       Date:  2009-12-10       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.